Jan-08-21 Downgrade
Wells Fargo
Overweight → Equal Weight
$21
Oct-05-20 Upgrade
Northland Capital
Market Perform → Outperform
$24
May-01-20 Initiated
Northland Capital
Outperform
$23
Mar-13-19 Downgrade
Piper Jaffray
Overweight → Neutral
$24 → $23
Mar-13-19 Downgrade
Needham
Buy → Hold
Aug-10-18 Reiterated
Needham
Buy
$24 → $22
Mar-13-18 Reiterated
Needham
Buy
$23 → $24
Dec-01-17 Reiterated
Needham
Buy
$20 → $23
Nov-09-17 Downgrade
Raymond James
Outperform → Mkt Perform
Sep-27-17 Reiterated
Needham
Buy
$18 → $20
Mar-14-17 Downgrade
Raymond James
Strong Buy → Outperform
Aug-09-16 Reiterated
Needham
Buy
$20 → $22
May-10-16 Reiterated
Needham
Buy
$21 → $20
Feb-19-16 Initiated
Wells Fargo
Outperform
Jun-19-15 Reiterated
Needham
Buy
$17 → $21
Jun-03-15 Initiated
Raymond James
Strong Buy
Jul-21-14 Initiated
Needham
Buy
$17
Feb-26-21 06:01AM
Feb-07-21 11:23PM
Dec-29-20 09:10AM
08:38AM
08:09AM
06:00AM
Dec-24-20 11:46PM
Dec-11-20 08:55AM
Dec-07-20 10:56AM
Dec-03-20 09:25PM
Nov-06-20 05:00PM
10:45AM
09:05AM
07:52AM
06:50AM
Nov-05-20 10:06AM
Oct-30-20 12:30PM
Oct-29-20 04:05PM
Oct-23-20 12:45PM
Oct-14-20 07:26AM
06:10AM
Oct-07-20 12:45PM
Oct-06-20 06:00AM
Oct-05-20 10:44AM
Sep-08-20 06:59AM
Sep-03-20 04:05PM
Aug-06-20 04:05PM
Aug-05-20 12:18PM
Aug-03-20 08:05AM
Jul-30-20 04:05PM
Jul-29-20 12:33PM
Jul-03-20 11:59AM
Jun-19-20 06:05AM
Jun-12-20 04:17PM
06:30AM
Jun-09-20 09:52AM Investor's Business Daily
06:00AM
Jun-02-20 04:05PM
May-11-20 01:24AM Thomson Reuters StreetEvents
May-09-20 08:21AM
May-08-20 04:31PM
May-07-20 04:05PM
May-06-20 12:10PM
May-04-20 06:01AM
Apr-27-20 06:00AM
Apr-13-20 05:16PM
Apr-09-20 06:01AM
Mar-31-20 10:56AM Thomson Reuters StreetEvents
Mar-29-20 08:36AM
Mar-25-20 09:33AM
Mar-24-20 09:47AM
Mar-20-20 10:44AM
Mar-12-20 06:05PM
04:05PM
03:00PM
Mar-05-20 04:05PM
Mar-03-20 12:30PM
Feb-27-20 06:00AM
Feb-13-20 05:48AM
Jan-29-20 08:30AM
Jan-28-20 04:05PM
Jan-08-20 05:15AM
Dec-17-19 07:19PM
Dec-10-19 10:25PM Thomson Reuters StreetEvents
Dec-02-19 05:16AM
Nov-27-19 06:00AM
Nov-15-19 06:00AM
Nov-07-19 04:05PM
Nov-01-19 06:00AM
Oct-28-19 02:14PM
Oct-21-19 06:17AM
Sep-21-19 07:58AM
Sep-12-19 09:15PM
Sep-01-19 09:38PM Thomson Reuters StreetEvents
Aug-29-19 06:01AM
Aug-22-19 08:44AM
Aug-07-19 11:24PM
08:55PM
04:05PM
Aug-05-19 06:00AM
Jul-23-19 01:19PM
Jun-29-19 06:18PM
Jun-24-19 06:00AM
Jun-19-19 06:00AM
Jun-14-19 02:07PM
06:00AM
May-31-19 06:00AM
May-28-19 02:47PM
May-21-19 01:33AM Thomson Reuters StreetEvents
May-10-19 06:00AM
12:24AM
May-09-19 07:05PM
05:58PM
04:05PM
May-07-19 10:56AM
May-06-19 06:00AM
May-01-19 10:33AM
Apr-26-19 09:30AM
Apr-25-19 03:13PM
Apr-15-19 09:30AM
Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; naloxone for opioid overdose; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; and Cortrosyn, a lyophilized powder use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; lidocaine jelly, a local anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection for newborn babies; atropine, calcium chloride, dextrose, epinephrine, lidocaine, and sodium bicarbonate for emergency use in hospital settings; morphine injection; and lorazepam injection for surgery and medical procedures. In addition, it offers procainamide for documented ventricular arrhythmias; neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; medroxyprogesterone acetate injectable suspension for the prevention of pregnancy; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block, as well as recombinant human insulin API (active pharmaceutical ingredients) and porcine insulin API. Further, the company has a pipeline of 20 product candidates in various stages of development for various indications. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Zhang Jack Y. CEO & Chief Scientific Officer Feb 18 Sale 18.58 407 7,562 6,827,679 Feb 18 06:58 PM Zhang Jack Y. CEO & Chief Scientific Officer Feb 17 Sale 18.67 13,801 257,723 6,828,086 Feb 18 06:58 PM Zhang Jack Y. CEO & Chief Scientific Officer Feb 16 Sale 18.51 16,259 301,031 6,841,887 Feb 18 06:58 PM Zhang Jack Y. CEO & Chief Scientific Officer Feb 12 Sale 18.94 13,277 251,522 6,858,146 Feb 12 07:11 PM Zhang Jack Y. CEO & Chief Scientific Officer Feb 11 Sale 19.06 19,823 377,884 6,871,423 Feb 12 07:11 PM Zhang Jack Y. CEO & Chief Scientific Officer Feb 10 Sale 18.76 15,747 295,344 6,891,246 Feb 12 07:11 PM Zhang Jack Y. CEO & Chief Scientific Officer Feb 09 Sale 18.93 11,927 225,776 6,906,993 Feb 09 05:30 PM Zhang Jack Y. CEO & Chief Scientific Officer Feb 08 Sale 18.89 13,452 254,049 6,918,920 Feb 09 05:30 PM Zhang Jack Y. CEO & Chief Scientific Officer Feb 05 Sale 18.94 15,507 293,721 6,932,372 Feb 09 05:30 PM Zhang Jack Y. CEO & Chief Scientific Officer Feb 04 Sale 18.89 25,570 483,020 6,947,879 Feb 05 08:35 PM Zhang Jack Y. CEO & Chief Scientific Officer Feb 03 Sale 18.36 16,299 299,323 6,973,449 Feb 05 08:35 PM Zhang Jack Y. CEO & Chief Scientific Officer Feb 02 Sale 18.66 13,817 257,821 6,989,748 Feb 03 04:15 PM Zhang Jack Y. CEO & Chief Scientific Officer Feb 01 Sale 18.29 24,114 441,120 7,003,565 Feb 03 04:15 PM Petersen Floyd F. Director Feb 01 Sale 18.26 639 11,669 73,354 Feb 02 04:16 PM PETERS WILLIAM J CFO, SVP & Treasurer Jan 19 Sale 18.67 6,495 121,237 89,548 Jan 20 05:58 PM Petersen Floyd F. Director Dec 01 Sale 17.87 500 8,936 73,993 Dec 02 04:20 PM Petersen Floyd F. Director Nov 02 Sale 19.84 500 9,920 74,493 Nov 03 04:05 PM Petersen Floyd F. Director Oct 01 Sale 18.89 500 9,446 74,993 Oct 02 04:15 PM Petersen Floyd F. Director Sep 01 Sale 19.90 500 9,948 75,493 Sep 02 05:27 PM Maris David Director Aug 14 Buy 20.26 1,000 20,260 13,151 Aug 18 04:15 PM PETERS WILLIAM J CFO, SVP & Treasurer Aug 14 Sale 20.36 5,512 112,223 95,652 Aug 18 04:12 PM PRINS RICHARD K Director Aug 11 Sale 20.33 6,000 121,976 39,160 Aug 12 06:34 PM Petersen Floyd F. Director Aug 03 Sale 20.62 500 10,308 75,993 Aug 04 08:22 PM Liawatidewi Yakob EVP Corp Admin Center Jul 21 Option Exercise 11.33 5,978 67,731 51,974 Jul 22 06:28 PM Liawatidewi Yakob EVP Corp Admin Center Jul 21 Sale 21.22 5,978 126,837 45,996 Jul 22 06:28 PM Liawatidewi Yakob EVP Corp Admin Center Jul 20 Option Exercise 11.33 4,186 47,427 50,182 Jul 22 06:28 PM Liawatidewi Yakob EVP Corp Admin Center Jul 20 Sale 21.03 4,186 88,047 45,996 Jul 22 06:28 PM PETERS WILLIAM J CFO, SVP & Treasurer Jul 06 Option Exercise 11.33 10,000 113,300 114,820 Jul 08 04:05 PM PETERS WILLIAM J CFO, SVP & Treasurer Jul 06 Sale 22.00 13,656 300,405 101,164 Jul 08 04:05 PM Petersen Floyd F. Director Jul 01 Sale 22.27 500 11,136 76,493 Jul 02 07:36 PM Liawatidewi Yakob EVP Corp Admin Center Jun 09 Option Exercise 10.93 16,000 174,880 69,529 Jun 10 07:39 PM Liawatidewi Yakob EVP Corp Admin Center Jun 09 Sale 20.41 23,405 477,602 46,124 Jun 10 07:39 PM Zhou Rong EVP, Production Center Jun 04 Option Exercise 11.41 8,918 101,754 89,042 Jun 05 04:15 PM Zhou Rong EVP, Production Center Jun 04 Sale 19.19 9,806 188,177 79,236 Jun 05 04:15 PM Zhou Rong EVP, Production Center Jun 03 Option Exercise 11.41 11,082 126,446 93,287 Jun 05 04:15 PM Zhou Rong EVP, Production Center Jun 03 Sale 18.82 13,163 247,678 80,124 Jun 05 04:15 PM Petersen Floyd F. Director Jun 01 Sale 18.97 500 9,483 71,142 Jun 02 05:46 PM Koo Richard Director May 27 Option Exercise 15.11 47,782 721,986 295,201 May 28 04:05 PM Koo Richard Director May 27 Sale 18.18 47,782 868,892 247,419 May 28 04:05 PM Lee Howard Director May 26 Option Exercise 15.11 10,000 151,100 138,081 May 27 05:02 PM Lee Howard Director May 26 Sale 18.60 10,000 185,989 128,081 May 27 05:02 PM Lee Howard Director May 22 Option Exercise 15.11 10,000 151,100 138,081 May 27 05:02 PM Lee Howard Director May 22 Sale 18.36 10,000 183,639 128,081 May 27 05:02 PM Lee Howard Director May 21 Option Exercise 15.11 10,000 151,100 138,081 May 22 04:05 PM Lee Howard Director May 21 Sale 18.47 10,000 184,687 128,081 May 22 04:05 PM Lee Howard Director May 20 Option Exercise 15.11 17,782 268,686 145,863 May 22 04:05 PM Lee Howard Director May 20 Sale 18.43 17,782 327,779 128,081 May 22 04:05 PM Petersen Floyd F. Director May 15 Option Exercise 15.11 42,682 644,925 114,324 May 18 04:31 PM ZASLOFF MICHAEL A Director May 15 Option Exercise 15.11 22,950 346,775 58,286 May 18 04:36 PM ZASLOFF MICHAEL A Director May 15 Sale 18.03 22,950 413,681 35,336 May 18 04:36 PM Petersen Floyd F. Director May 15 Sale 18.25 42,682 778,968 71,642 May 18 04:31 PM Petersen Floyd F. Director May 14 Option Exercise 15.11 5,000 75,550 76,642 May 18 04:31 PM ZASLOFF MICHAEL A Director May 14 Option Exercise 15.11 14,832 224,112 50,168 May 18 04:36 PM ZASLOFF MICHAEL A Director May 14 Sale 18.00 14,832 266,976 35,336 May 18 04:36 PM Petersen Floyd F. Director May 14 Sale 17.78 5,000 88,876 71,642 May 18 04:31 PM Petersen Floyd F. Director May 12 Option Exercise 15.11 100 1,511 71,742 May 14 04:15 PM PRINS RICHARD K Director May 12 Option Exercise 15.11 30,282 457,561 69,591 May 14 04:17 PM ZASLOFF MICHAEL A Director May 12 Option Exercise 15.11 10,000 151,100 45,336 May 14 04:18 PM ZASLOFF MICHAEL A Director May 12 Sale 19.00 10,000 190,000 35,336 May 14 04:18 PM PRINS RICHARD K Director May 12 Sale 19.00 30,282 575,419 39,309 May 14 04:17 PM Petersen Floyd F. Director May 12 Sale 19.20 100 1,920 71,642 May 14 04:15 PM Petersen Floyd F. Director May 01 Sale 16.66 500 8,329 71,642 May 05 05:05 PM Petersen Floyd F. Director Apr 01 Sale 14.36 500 7,181 72,142 Apr 02 05:46 PM PETERS WILLIAM J CFO, SVP & Treasurer Mar 13 Sale 13.94 4,701 65,539 74,274 Mar 17 08:07 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite